Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.
Inclusion Criteria:
Exclusion Criteria: